… era of type 1 diabetes treatment is emerging, but only … United States Food and Drug Administration (FDA) approval of teplizumab … Stage 3 trials (for example, the PROTECT trial) shows … overall safety. Inhaled human insulin (Afrezza) offers the fastest onset …

… past users of technosphere insulin (Afrezza, MannKind Corp.). In … technosphere insulin from their doctor, with the remaining participants stating … clinical director of Integrated Diabetes Services in Wynnewood, … is a life-sustaining drug. Healio: What further …

… , a non-antibiotic treatment for patients suffering from … first to launch this treatment in India, it … Medical Officer, Cipla. Earlier last year, the Indian regulator, the Central Drugs … insulin known as Afrezza, which is used to help adults with diabetes …

We recently published 10 Best Biotech Stocks to Buy Under $10. … flagship product, Afrezza, is a rapid-acting inhaled insulin, and the … positive Phase 3 INHALE-1 trial data demonstrating safety and … planned to enter Phase 2 trials by year-end. The corporation …

… . It is currently only FDA approved in adults, but … License Application to the FDA for a pediatric indication. … for presentation at a medical meeting sometime in the … , discusses inhaled insulin and Afrezza data for type 1 diabetes. Contemporary Pediatrics …

… 1 diabetes treatments in history, with new medications that … options, and drugs that improve insulin resistance. It’ … treatment called zimislecel has shown promising results in early trials … inhaled insulin Afrezza provides rapid delivery of insulin to …

… INHALE-1 trial, which supported MannKind’s August 2025 FDA filing for … of inhaled insulin in managing challenging meals and easing early treatment transitions … , MD, discusses inhaled insulin and Afrezza data for type 1 diabetes. Contemporary Pediatrics …

… trial. INHALE-1 Children and adolescents with diabetes assigned technosphere insulin (Afrezza … professor of diabetes medicine at the … trials. Haller M, et al. From discovery to treatment … Pharma, Hanmi Pharmaceutical, Lexicon Pharmaceuticals, Novo Nordisk …

… the FDA for its inhaled insulin Afrezza for … Reviewing triggers, confirming medication refills, and fostering … of its reference drug, tocilizumab (Actemra; … FDA approved fremanezumab-vfrm (Ajovy; Teva Pharmaceuticals) injection for preventive treatment …

… Application to the FDA for its inhaled insulin Afrezza for a pediatric … for presentation at a medical meeting sometime in the … shift in how T1D treatment is looked at, utilization … children with type 1 diabetes. American Diabetes Association. Press release. …